PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Clinical trial NCT07142291 · RECRUITING

Trial details

NCT number: NCT07142291
Sponsor: PhenoNet, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-11-25
Primary completion: 2027-03-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.